Meal timing and stomach acid drugs may change how this experimental drug works

NCT ID NCT07700953

Not yet recruiting Knowledge-focused Sponsor: Abbisko Therapeutics Co, Ltd Source: ClinicalTrials.gov ↗

First seen Jul 14, 2026 · Last updated Jul 15, 2026 · Updated 1 time

Summary

This study in healthy adults aged 18 to 45 examines how different meals (low-fat vs. high-fat) and the stomach-acid drug omeprazole affect the body's absorption of an experimental drug called ABSK-011. In one part, participants take ABSK-011 after different meals to see how food changes drug levels. In another part, they take ABSK-011 with omeprazole to check for interactions. The goal is to guide future dosing instructions.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: ABSK-011 capsules and omeprazole enteric-coated tablets
What this could lead to: If successful, this study could help determine the best way to take ABSK-011 in future trials, potentially improving its effectiveness and safety.
What could go wrong: This is an early-phase study in healthy volunteers, not patients, so results may not predict how the drug works in people with a disease. The small sample size (30 people) limits generalizability.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEALTHY PARTICIPANTS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HEALTHY PARTICIPANTS

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.